1. Home
  2. FTV vs BIIB Comparison

FTV vs BIIB Comparison

Compare FTV & BIIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortive Corporation

FTV

Fortive Corporation

HOLD

Current Price

$54.73

Market Cap

19.1B

Sector

Industrials

ML Signal

HOLD

Logo Biogen Inc.

BIIB

Biogen Inc.

HOLD

Current Price

$218.12

Market Cap

29.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTV
BIIB
Founded
2015
1978
Country
United States
United States
Employees
18000
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1B
29.9B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
FTV
BIIB
Price
$54.73
$218.12
Analyst Decision
Hold
Buy
Analyst Count
11
25
Target Price
$59.18
$206.83
AVG Volume (30 Days)
1.6M
630.6K
Earning Date
04-30-2026
04-29-2026
Dividend Yield
0.39%
N/A
EPS Growth
N/A
N/A
EPS
0.44
2.15
Revenue
$6,452,700,000.00
$9,890,600,000.00
Revenue This Year
$4.85
N/A
Revenue Next Year
$3.74
N/A
P/E Ratio
$126.89
$98.01
Revenue Growth
12.10
2.22
52 Week Low
$47.31
$135.39
52 Week High
$64.56
$225.80

Technical Indicators

Market Signals
Indicator
FTV
BIIB
Relative Strength Index (RSI) 27.53 51.39
Support Level $52.95 $184.50
Resistance Level $56.19 $219.24
Average True Range (ATR) 1.06 5.27
MACD -0.45 -1.05
Stochastic Oscillator 1.76 38.77

Price Performance

Historical Comparison
FTV
BIIB

About FTV Fortive Corporation

Fortive Corp is a diversified industrial technology firm offering essential technologies, software, and services globally across several industries, such as manufacturing, utilities, medical, electronics, etc. It has two reportable segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Maximum revenue is generated from the Intelligent Operating Solutions segment, which offers professional instruments used in applications like maintenance, repair, measurement, and condition monitoring, connected worker safety, compliance solutions, etc. The products and services in this segment are marketed under various brands, including Fluke, Servicechannel, Gordian, Accruent, Industrial Scientific, and Intelex. Geographically, the firm generates maximum revenue from North America.

About BIIB Biogen Inc.

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

Share on Social Networks: